Skip to content

Free cash flow margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
WAT
Waters CorporationWAT
7%-13.8pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-119%-21.2pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
-13%-3.6pp
Lifetime Brands logo
Lifetime BrandsLCUT
3%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-110.5%-14.9pp

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-34.8%
Enterprise value$117.3M-28.0%
P/E10.6×-3.1×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Calculated from Kewaunee Scientific Corporation’s reported figures.

Based on trailing twelve months.

The official record: Kewaunee Scientific Corporation’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's free cash flow margin?
Kewaunee Scientific Corporation (KEQU) reported free cash flow margin of 5.2% in Q1 2026.
What is the long-term trend for Kewaunee Scientific Corporation's free cash flow margin?
Over 2 years (2023 to 2026), Kewaunee Scientific Corporation's free cash flow margin has grown at a 20.0% compound annual growth rate (CAGR), from -3.6% to 5.2%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.